Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The ...

Researchers at Stony Brook University used genetic manipulation in a laboratory brain model to demonstrate that neurosteroids ...

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...

This study presents solid evidence for distinct neurotransmitter release modalities between two subclasses of dopaminergic neurons in the olfactory bulb, highlighting an important finding that ...

Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...

Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Inc. (NYSE American: PTN) has announced the completion of their Phase 2 clinical trial for an obesity treatment, marking a ...

This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...

A RECENT population-based analysis has highlighted potential behavioural side effects associated with Glucagon-like peptide 1 receptor agonists (GLP1RA). These medications, widely used for managing ...